Document Detail


Bacterial vaginosis in pregnancy: an approach for the 1990s.
MedLine Citation:
PMID:  7659396     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
It is proposed that clinicians screen all pregnant women at high risk for preterm labor and premature rupture of membranes for bacterial vaginosis, and treat all women when it is diagnosed. This infection is associated with a two to three times increase in preterm labor and delivery, premature rupture of the membranes, and endometritis. Although cause and effect have not been conclusively documented, these associations must be considered in the practice of obstetrics at the present. The paucity of vaginal Lactobacillus spp is pivotal in allowing overgrowth of many other organisms of the vagina. Screening is suggested because 50 percent of bacterial vaginosis is asymptomatic. The diagnosis, which is rapidly made and inexpensive, remains defined by clue cells seen on wet prep, high vaginal pH, and amine odor of the vaginal discharge. Optimal treatment of pregnant women with bacterial vaginosis is via oral or intravaginal metronidazole or clindamycin.
Authors:
M C McCoy; V L Katz; J A Kuller; A P Killam; C H Livengood
Related Documents :
18316286 - Vaginal douching among university women in the southeastern united states.
9764936 - Vulvovaginal candidiasis in female sex workers.
369376 - Group b streptococcal colonization and antibody status in lower socioeconomic parturien...
12193926 - Urbanization and baseline prevalence of genital infections including candida, trichomon...
16393296 - Statins and the risk of acute pancreatitis: a population-based case-control study.
9827886 - Risk assessment of hazardous release in air due to the chemical production of "p. karam...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Obstetrical & gynecological survey     Volume:  50     ISSN:  0029-7828     ISO Abbreviation:  Obstet Gynecol Surv     Publication Date:  1995 Jun 
Date Detail:
Created Date:  1995-10-05     Completed Date:  1995-10-05     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  0401007     Medline TA:  Obstet Gynecol Surv     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  482-8     Citation Subset:  IM    
Affiliation:
University of North Carolina, Department of Obstetrics and Gynecology, Chapel Hill, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Clindamycin / administration & dosage
Female
Fetal Membranes, Premature Rupture / prevention & control
Gestational Age
Humans
Metronidazole / administration & dosage
Obstetric Labor, Premature / prevention & control
Pregnancy
Pregnancy Complications, Infectious / diagnosis*,  drug therapy
Risk Factors
Vaginitis / diagnosis*
Vaginosis, Bacterial / diagnosis*,  drug therapy
Chemical
Reg. No./Substance:
18323-44-9/Clindamycin; 443-48-1/Metronidazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transfusion medicine in obstetrics and gynecology.
Next Document:  Adsorption of small biological molecules on silica from diluted aqueous solutions: quantitative char...